Use of bronchoalveolar lavage in humans - Past necessity and future imperative

Lung

Volumn 178, Issue 5, 2000, Pages 271-293

  Reynolds, H Y ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Bronchoalveolar lavage; Diffuse interstitial lung disease; Fiberoptic bronchoscopy

Indexed keywords

ANALYTIC METHOD; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; FIBEROPTIC BRONCHOSCOPY; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG LAVAGE; PRIORITY JOURNAL; TRANSBRONCHIAL BIOPSY;

BRONCHOALVEOLAR LAVAGE; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; FORECASTING; HUMANS; LUNG DISEASES, INTERSTITIAL;

EID: 0034535669     PISSN: 03412040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004080000032     Document Type: Article

References (138)

1. Functional diversity of helper T lymphocytes
2. Age-related modification of BAL cell profile in UIP and sarcoidosis
3. Increasing the quality of hematopathology laboratories in interpreting bronchoalveolar lavage samples
4. Bronchoalveolar lavage fluid - A new material in pulmonology
5. Bronchoalveolar lavage
6. Induction of aryl hydrocarbon hydroxylase in human pulmonary alveolar macrophages by cigarette smoking
7. A new flexible double-lumen catheter for bronchospirometry
8. Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis
9. Natural history and treated course of usual and desquamative interstitial pneumonia
10. Multimedial atlas of BAL cytopathology. 1. Outline of the contents. 2. Possibility to use the atlas as CD-ROM
11. The human alveolar macrophage: Isolation, cultivation in vitro and studies of morphologic functional characteristics
12. Pulmonary fibrosis - Pathways are slowly coming to light (perspective)
13. Bronchoalveolar lavage: A standardized procedure or a technical dilemma?
14. Bronchoalveolar lavage: Interim evaluation following 10 years clinical use
15. Interstitial lung diseases of unknown cause: Disorders characterized by chronic inflammation of the lower respiratory tract
16. Idiopathic pulmonary fibrosis - Clinical, histologic, radiologic, physiologic, scintigraphic, cytologic and biochemical aspects
17. Bronchoalveolar lavage. The report of an international conference
18. Immunocompetent cells from the lower respiratory tract of normal human lungs
19. Bronchoalveolar lavage: Role in the pathogenesis, diagnosis, and management of interstitial lung disease
20. Bronchoalveolar cell populations in acute sarcoidosis: Observations in smoking and nonsmoking patients
21. Bronchoalveolar lavage and the technological dilemma
22. Analysis of airspace and interstitial mononuclear cell populations in human diffuse interstitial lung disease
23. Analyses of sequential bronchoalveolar lavage samples from healthy human volunteers
24. Characteristics of diffuse lung disease reflected by pulmonary lavage
25. Predicting computer program using cellular BAL fluid analysis results: An update
26. A computer program using BALF-analysis results as a diagnostic tool in interstitial lung diseases
27. Diffuse lung disease: An approach to management
28. Low yield of pulmonary surfactant in cigarette smokers
29. Bronchopulmonary lavage in normal subjects and patients with obstructive lung disease
30. Bronchoalveolar lavage
31. Bronchoalveolar lavage: A decade later
32. Bronchoalveolar lavage
33. The role of bronchoalveolar lavage in the assessment of diffuse lung diseases
34. Potential therapeutic initiatives for fibrogenic lung diseases - Impact of basic research on tomorrow's medicine
35. Official American Thoracic Society statement - Clinical role of bronchoalveolar lavage in adults with pulmonary disease
36. The J. Burns Amberson lecture-in defense of the lung
37. Human alveolar macrophages: Comparison of phagocytic, glucose utilization, and ultrastructure in smokers and nonsmokers
38. Bronchoalveolar lavage
39. Evaluation of alveolitis by studies of lung biopsies
40. Report of ERS Task Force: Guidelines for measurement of acellular components and standardization of BAL
41. Mast cells, atypical lymphocytes, and neutrophils in bronchoalveolar lavage in extrinsic allergic alveolitis - Comparison with other interstitial lung diseases
42. Bronchoalveolar lavage in pulmonary fibrosis: Comparison of cells obtained with lung biopsy and clinical features
43. Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy
44. Clinical usefulness of bronchoalveolar lavage
45. Localization of the immune response in sarcoidosis
46. Inflammatory and immune processes in the human lung in health and disease: Evaluation by bronchoalveolar lavage
47. Characterization of inflammatory and immune effector cells in the lung parenchyma of patients with interstitial lung disease
48. Flexible bronchofiberscope
49. Flexible hronchofiberscope
50. A comparison of albumin and urea as reference markers in bronchoalveolar lavage fluid from patients with interstitial lung disease
51. Immunoglobulins in normal human tracheobronchial washings: A qualitative and quantitative study
52. Effect of intermittent high dose parenteral corticosteroids on the alveolitis of idiopathic pulmonary fibrosis
53. Clinical guidelines and indications for bronchoalveolar lavage (BAL): Report of the European Society of Pneumology Task Force on BAL
54. Clinical utility of bronchoalveolar lavage in a general hospital
55. Immunoglobulin secreting cells in normal human bronchial lavage
56. Lung T cells in hypersensitivity pneumonitis
57. Transbronchial lung biopsy via the fiberoptic bronchoscope
58. Desquamative interstitial pneumonia
59. Newly identified proteins in human nasal and bronchoalveolar lavage fluids: Potential biomedical and clinical applications
60. Biochemical analyses of bronchoalveolar lavage fluids of normal healthy volunteers
61. Neutrophilic alveolits in idiopathic pulmonary fibrosis: The role of interleukin-8
62. Alveolar macrophages: Structural and functional differences between nonsmokers and smokers of marijuana and tobacco
63. Limitations of using urea to quantify epithelial lining fluid recovered by bronchoalveolar lavage
64. Interstitial lung disease. Assessments by bronchoalveolar lavage
65. Bronchoalveolar lavage
66. Studies on the proteins of human bronchial secretions
67. Pharmacological therapy for idiopathic pulmonary fibrosis - Past, present and future (NHLBI workshop summary 9/9-10/1998)
68. Diagnosis of interstitial lung diseases using bronchoalveolar lavage
69. Kinetic analysis of respiratory tract proteins recovered during a sequential lavage protocol
70. Bronchial lavage in inflammatory lung disease
71. Le catheteriseme bronchique
72. Bronchoalveolar lavage studies in children without parenchymal lung disease: Cellular constituents and protein levels
73. The many uses of bronchoalveolar lavage
74. Lysozyme content of alveolar and peritoneal macrophages from the rabbit
75. The diagnostic accuracy of high-resolution computed tomography in diffuse infiltrative lung diseases
76. The sensitivity of high-resolution CT in detecting idiopathic pulmonary fibrosis proved by open lung biopsy
77. Neutrophil chemotactic factors in the respiratory tract of patients with chronic airway diseases or idiopathic pulmonary fibrosis
78. Cell adhesional molecules and pulmonary fibrosis
79. Pulmonary surfactant modulation of host-defense function
80. Surfactant regulation of host-defense function in the lung: A question of balance
81. Effect of location, pH and temperature of instillate in bronchoalveolar lavage in normal subjects
82. A comparison of alveolar macrophages and pulmonary surfactant (?) obtained from the lungs of human smokers and nonsmokers by endobronchial lavage
83. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: A prospective study
84. Bronchopulmonary lavage in man
85. What is today's role for bronchoalveolar lavage?
86. Use of a central laboratory for analysis of bronchoalveolar lavage fluid
87. Bronchoalveolar lavage - Its safety in mild asthma
88. Lymphocyte subsets in bronchoalveolar lavage fluid of children without bronchopulmonary disease
89. Future directions for bronchoalveolar lavage
90. Estimations of the absolute volume of epithelial lining fluid recovered by bronchoalveolar lavage using urea as an endogenous marker of dilution
91. Fractional processing of sequential bronchoalveolar lavage to separate bronchial and alveolar samples
92. Immunologic lung disease
93. Idiopathic interstitial pulmonary fibrosis: Contribution of bronchoalveolar lavage analysis
94. Bronchoalveolar lavage - State of art
95. Diagnostic and management strategies for diffuse interstitial lung disease
96. Advances in understanding pulmonary host defense mechanisms: Dendritic cell function and immunomodulation
97. Receptors for immunoglobulin and complement on human alveolar macrophages
98. Respiratory tract fluids: Analysis of content and contemporary use in understanding lung disease
99. Analysis of cellular and protein components of bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis and hypersensitivity pneumonitis
100. Specificity of opsonic antibodies to enhance phagocytosis of Pseudomonas aeruginosa by human alveolar macrophages
101. Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage
102. Pulmonary host defenses I. Analysis of protein and lipids in bronchial secretions and antibody responses after vaccination with Pseudomonas aeruginosa
103. Pulmonary host defenses II. Interaction of respiratory antibodies with Pseudomonas aeruginosa and alveolar macrophages
104. Bronchoalveolar lavage cellularity in healthy children
105. Bronchoalveolar lavage sampling of airway and alveolar cells
106. Role of bronchopulmonary lavage in the treatment of respiratory failure - A review
107. Bronchoalveolar lavage in the investigation of disorders of the lower respiratory tract
108. Bronchoalveolar lavage during fiberoptic bronchoscopy: What has it brought to pulmonary medicine?
109. Cryptogenic fibrosing alveolitis-relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis
110. Applications of bronchofiberoscopy
111. Accurate quantification of cells recovered by bronchoalveolar lavage
112. Diffuse fibrosing alveolitis (diffuse interstitial fibrosis of the lungs) correlation of histology at biopsy with prognosis
113. Detection of nonvolatile macromolecules in breath - A possible diagnostic tool
114. Bronchoalveolar lavage and lung histology - Comparative analysis of inflammatory and immunocompetent cells in patients with sarcoidosis and hypersensitivity pneumonitis
115. Flexible fiberoptic bronchoscope
116. Bronchoalveolar lavage in asthma. An update and perspective
117. Bronchoalveolar lavage today
118. Interleukin-8: Differential expression in lone fibrosing alveolitis and systemic sclerosis
119. The clinical use of bronchoalveolar lavage
120. Safety of bronchoalveolar lavage in patients with adult respiratory distress syndrome
121. The impact of bronchoalveolar lavage cell analysis on clinicians' diagnostic reasoning about interstitial lung disease
122. Safety of fiberoptic bronchoalveolar lavage in evaluation of interstitial lung disease
123. Technical recommendations and guidelines for bronchoalveolar lavage (BAL) - Report of the European Society of Pneumology Task Group on BAL
124. Idiopathic nonspecific interstitial pneumonia: Prognostic significance of cellular and fibrosing patterns - Survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia
125. Clinical applications of bronchoalveolar lavage: An interim view
126. Clinical applications of bronchoalveolar lavage
127. The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with crytogenic fibrosing alveolitis
128. Distribution and immunophenotype of mononuclear phagocytes and dendritic cells in the human lung
129. Immune response of the human respiratory tract: Immunoglobulin levels and influenza virus vaccine antibody response
130. Lung inflammation and fibrosis
131. Normal human bronchial immunoglobulin and proteins: Effects of cigarette smoking
132. Idiopathic pulmonary fibrosis. Pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy
133. Bronchoalveolar lavage in interstitial lung disease
134. The predictive value of appearance of thin section computed tomography in fibrosing alveolitis
135. Sarcoidosis: Analysis of cells obtained by bronchial lavage
136. Pinocytosis by human alveolar macrophages: Comparison of smokers and nonsmokers
137. Bronchoalveolar lavage cells and proteins in patients with the acquired immunodeficiency syndrome - An immunologic analysis